ArticleBMC cancer2022

Anti-lipolysis-stimulated lipoprotein receptor monoclonal antibody as a novel therapeutic agent for endometrial cancer.

Yoshikazu Nagase et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.